Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1995 1
1996 1
1997 1
1998 4
2001 1
2002 1
2003 2
2005 1
2006 4
2007 1
2008 4
2009 2
2010 3
2011 2
2012 2
2013 3
2014 3
2015 2
2016 3
2017 3
2018 8
2019 4
2020 6
2021 11
2022 4
2023 8
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
The myotonic dystrophy type 1 drug development pipeline: 2022 edition.
Pascual-Gilabert M, Artero R, López-Castel A. Pascual-Gilabert M, et al. Among authors: artero r. Drug Discov Today. 2023 Mar;28(3):103489. doi: 10.1016/j.drudis.2023.103489. Epub 2023 Jan 9. Drug Discov Today. 2023. PMID: 36634841 Free article. Review.
Myotonic dystrophy type 1 drug development: A pipeline toward the market.
Pascual-Gilabert M, López-Castel A, Artero R. Pascual-Gilabert M, et al. Among authors: artero r. Drug Discov Today. 2021 Jul;26(7):1765-1772. doi: 10.1016/j.drudis.2021.03.024. Epub 2021 Mar 31. Drug Discov Today. 2021. PMID: 33798646 Free PMC article. Review.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, Álvarez ÉMC, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Au… See abstract for full author list ➔ Klionsky DJ, et al. Among authors: artero r. Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280. Epub 2021 Feb 8. Autophagy. 2021. PMID: 33634751 Free PMC article.
RNA-mediated therapies in myotonic dystrophy.
Overby SJ, Cerro-Herreros E, Llamusi B, Artero R. Overby SJ, et al. Among authors: artero r. Drug Discov Today. 2018 Dec;23(12):2013-2022. doi: 10.1016/j.drudis.2018.08.004. Epub 2018 Aug 4. Drug Discov Today. 2018. PMID: 30086404 Free article. Review.
MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy.
López Castel A, Overby SJ, Artero R. López Castel A, et al. Among authors: artero r. Int J Mol Sci. 2019 Nov 9;20(22):5600. doi: 10.3390/ijms20225600. Int J Mol Sci. 2019. PMID: 31717488 Free PMC article. Review.
Myotonic dystrophy: candidate small molecule therapeutics.
Konieczny P, Selma-Soriano E, Rapisarda AS, Fernandez-Costa JM, Perez-Alonso M, Artero R. Konieczny P, et al. Among authors: artero r. Drug Discov Today. 2017 Nov;22(11):1740-1748. doi: 10.1016/j.drudis.2017.07.011. Epub 2017 Aug 2. Drug Discov Today. 2017. PMID: 28780071 Free article. Review.
The hallmarks of myotonic dystrophy type 1 muscle dysfunction.
Ozimski LL, Sabater-Arcis M, Bargiela A, Artero R. Ozimski LL, et al. Among authors: artero r. Biol Rev Camb Philos Soc. 2021 Apr;96(2):716-730. doi: 10.1111/brv.12674. Epub 2020 Dec 2. Biol Rev Camb Philos Soc. 2021. PMID: 33269537 Review.
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression.
González-Martínez I, Cerro-Herreros E, Moreno N, García-Rey A, Espinosa-Espinosa J, Carrascosa-Sàez M, Piqueras-Losilla D, Arzumanov A, Seoane-Miraz D, Jad Y, Raz R, Wood MJ, Varela MA, Llamusí B, Artero R. González-Martínez I, et al. Among authors: artero r. Mol Ther Nucleic Acids. 2023 Sep 5;34:102024. doi: 10.1016/j.omtn.2023.09.001. eCollection 2023 Dec 12. Mol Ther Nucleic Acids. 2023. PMID: 37744174 Free PMC article.
Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila.
Chakraborty M, Llamusi B, Artero R. Chakraborty M, et al. Among authors: artero r. Front Neurol. 2018 Jul 16;9:473. doi: 10.3389/fneur.2018.00473. eCollection 2018. Front Neurol. 2018. PMID: 30061855 Free PMC article. Review.
79 results